[Interstitial brachytherapy in infiltrating cancer of the bladder. The Nancy experience].
Fiche publication
Date publication
avril 1998
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Dr LUPORSI Elisabeth, Pr PEIFFERT Didier
Tous les auteurs :
Hoffstetter S, Hubert J, Guillemin F, Peiffert D, Marchal C, Luporsi E, Pernot M
Lien Pubmed
Résumé
From 1975 to 1996, 98 patients with infiltrative vesical carcinomas were treated at the Centre Alexis Vautrin by conservative surgery and interstitial brachytherapy (192lr). The mean follow-up was about eight years. From this retrospective non randomized study, we tried to determine the tolerance to this treatment.
Mots clés
Brachytherapy, adverse effects, Carcinoma, Transitional Cell, pathology, Combined Modality Therapy, Cystectomy, Female, Humans, Iridium Radioisotopes, adverse effects, Lymph Node Excision, Male, Middle Aged, Neoplasm Invasiveness, Neoplasm Recurrence, Local, surgery, Neoplasm Staging, Radiopharmaceuticals, therapeutic use, Retrospective Studies, Survival Analysis, Urinary Bladder Neoplasms, pathology
Référence
Cancer Radiother. 1998 Apr;2 Suppl 1:54s-61s